Eng E - Search Results

1

Modulation of experimental mesangial proliferative nephritis by interferon-gamma.

Johnson RJ, Lombardi D, Eng E, Gordon K, Alpers CE, Pritzl P, Floege J, Young B, Pippin J, Couser WG, et al. Johnson RJ, et al. Among authors: eng e. Kidney Int. 1995 Jan;47(1):62-9. doi: 10.1038/ki.1995.7. Kidney Int. 1995. PMID: 7731171 Free article.

2

Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.

Floege J, Eng E, Lindner V, Alpers CE, Young BA, Reidy MA, Johnson RJ. Floege J, et al. Among authors: eng e. J Clin Invest. 1992 Dec;90(6):2362-9. doi: 10.1172/JCI116126. J Clin Invest. 1992. PMID: 1361494 Free PMC article.

3

Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.

Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh T, Bennett WM, Couser WG. Young BA, et al. Among authors: eng e. Kidney Int. 1995 Aug;48(2):439-48. doi: 10.1038/ki.1995.312. Kidney Int. 1995. PMID: 7564111 Free article.

4

Cellular events in the evolution of experimental diabetic nephropathy.

Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K. Young BA, et al. Among authors: eng e. Kidney Int. 1995 Mar;47(3):935-44. doi: 10.1038/ki.1995.139. Kidney Int. 1995. PMID: 7752595 Free article.

5

Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.

Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ. Floege J, et al. Among authors: eng e. J Clin Invest. 1993 Dec;92(6):2952-62. doi: 10.1172/JCI116918. J Clin Invest. 1993. PMID: 7902849 Free PMC article.

6

Is mesangial cell proliferation required for extracellular matrix expansion in glomerular disease?

Eng E, Floege J, Young BA, Alpers CE, Couser WG, Johnson RJ. Eng E, et al. Contrib Nephrol. 1994;107:156-62. doi: 10.1159/000422974. Contrib Nephrol. 1994. PMID: 8004962 Review. No abstract available.

7

Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?

Eng E, Floege J, Young BA, Couser WG, Johnson RJ. Eng E, et al. Kidney Int Suppl. 1994 Feb;45:S45-7. Kidney Int Suppl. 1994. PMID: 8158896 Review. No abstract available.

8

Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.

Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Floege J, et al. Among authors: eng e. Kidney Int. 1993 Feb;43(2):369-80. doi: 10.1038/ki.1993.55. Kidney Int. 1993. PMID: 8441232 Free article.

9

Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.

Floege J, Eng E, Young BA, Johnson RJ. Floege J, et al. Among authors: eng e. Kidney Int Suppl. 1993 Jan;39:S47-54. Kidney Int Suppl. 1993. PMID: 8468926 Review.

10

SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.

Pichler RH, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CE, Couser WG, Sage EH, Johnson RJ. Pichler RH, et al. Among authors: eng e. Am J Pathol. 1996 Apr;148(4):1153-67. Am J Pathol. 1996. PMID: 8644857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters